Alzheimer ta un malesa neurologico progresivo cu ta causa cu celnan di cerebro ta degenera y muri, cu ta conduci na un disminucion di memoria, pensamento y habilidad di rasonamento.
E ta e kousa mas komun di demensia, ku ta konta pa 60-80% di tur kaso.
E malesa ta fatal, ku un promedio di bida despues di diagnósis di 4-8 aña, maske algun hende por biba te ku 20 aña ku e malesa.
E tasa di mortalidat pa Alzheimer ta varia dependiendo di e estudio i e poblashon ku ta ser eksaminá.
Segun e Alzheimer's Association, Alzheimer ta e di seis causa di morto na Merca, y e di cinco causa di morto pa esnan di 65 aña of mas.
Na 2019, Alzheimer a keda raporta como e causa di morto pa 121.9444 persona na Merca.
Ta importante pa nota ku e tasa di mortalidat pa Alzheimer no ta solamente debí na e malesa mes, sino tambe na komplikashonnan i otro problema di salú ku ta surgi komo resultado di e malesa.
Segun e malesa ta progresá, e personanan por eksperensiá difikultat ku aktividatnan di bida diario, manera kome, baña i bisti, loke por kondusí na malnutrishon, infekshon i otro problema di salú.
Ademas, hende ku tin Alzheimer ta kore mas riesgo di kai, haña pneumonia i otro infekshon.
Aunke no tin cura pa Alzheimer, tin tratamento disponibel cu por yuda maneha sintomanan y mehora calidad di bida.
Investigashon ta kontinuá pa desaroyá tratamentunan nobo i finalmente haña un kura pa e malesa devastador aki.
Zhu B, Chen X, Li W, Zhou D: Effect of Alzheimer Disease on Prognosis of Intensive Care Unit (ICU) Patients: A Propensity Score Matching Analysis. Med Sci Monit. 2022, 28 (): e935397.
Almeida MC, Gomes Cde M, Nascimento LF: Spatial distribution of deaths due to Alzheimer's disease in the state of São Paulo, Brazil. Sao Paulo Med J. 2014, 132 (4): 199-204.
Aevarsson O, Svanborg A, Skoog I: Seven-year survival rate after age 85 years: relation to Alzheimer disease and vascular dementia. Arch Neurol. 1998, 55 (9): 1226-32.
Breitner JC: Clinical genetics and genetic counseling in Alzheimer disease. Ann Intern Med. 1991, 115 (8): 601-6.
Iulita MF, Garzón Chavez D, Klitgaard Christensen M, Valle Tamayo N, Plana-Ripoll O, Rasmussen SA, Roqué Figuls M, Alcolea D, Videla L, Barroeta I, Benejam B, Altuna M, Padilla C, Pegueroles J, Fernandez S, Belbin O, Carmona-Iragui M, Blesa R, Lleó A, Bejanin A, Fortea J: Association of Alzheimer Disease With Life Expectancy in People With Down Syndrome. JAMA Netw Open. 2022, 5 (5): e2212910.
['Disclaimer: médiko']
['E website aki ta pa informashon i edukashon so i no ta pa duna konseho médiko òf servisio profeshonal.']
['E informashon ku ta ser duná no mester ser usá pa diagnostiká òf trata un problema di salú òf malesa, i esnan ku ta buska konseho médiko personal mester konsultá ku un dòkter ku tin un pèrmit di traha.']
['Por fabor nota e reda neuronal ku ta generá kontesta na e preguntanan, ta spesialmente inakusá ora ta trata di kontenido numériko. Por ehèmpel, e kantidat di hende diagnostiká ku un malesa spesífiko.']
['Semper busca conseho di bo dokter of otro profesional di salud cualifica tocante un condicion medico. Nunca ignora conseho medico profesional of tarda pa busca esaki pa motibo di algo cu bo a lesa riba e website aki. Si bo ta kere cu bo por tin un emergencia medico, yama 911 of bay na e sala di emergencia mas cerca di bo mesora.']
['Copyright: Copyright']
['E Digital Millennium Copyright Act di 1998, 17 U.S.C. § 512 (e DMCA) ta duna derechi di rekurso pa doñonan di derechi di outor ku ta kere ku material ku ta aparesé riba internet ta violá nan derechi bou di lei di derechi di outor di Merka. ']
['Si bo ta kere di buena fe ku kualke kontenido òf material ku ta disponibel riba nos website òf servisio ta violá bo derechi di outor, abo (òf bo representante) por manda nos un notifikashon pa pidi pa kita e kontenido òf material òf pa blokia akseso na dje.']
["Mester manda e anunsio por eskrito via e-mail (wak e sekshon 'Kontacto' pa e-mail adrès)."]
['E DMCA ta eksigí ku bo notifikashon di violashon di derechi di outor ta inkluí e siguiente informashon: (1) deskripshon di e obra ku ta suheto di violashon; (2) deskripshon di e kontenido ku ta viola i informashon sufisiente pa nos por lokalisá e kontenido; (3) informashon di kontakto, inkluyendo bo adrès, number di telefòn i email; (4) un deklarashon di bo ku bo ta kere ku e kontenido no ta outorisá pa e doño di derechi di outor, su agente òf lei.']
['(5) un deklarashon di bo, firma bou di pena di huramentu falsu, ku e informashon den e notifikashon ta korekto i ku bo tin outoridat pa hasi uso di e derechonan di outor ku ta ser akusá di a wòrdu infringi;']
['i (6) un firma físiko òf elektróniko di e doño di derechi di outor òf un persona outorisá pa aktua na nòmber di e doño di derechi di outor.']
['Si bo no duna tur informashon ariba menshoná, e tratamentu di bo keho por tarda.']
['Kontakto']
['Por fabor manda nos un email ku kualke pregunta/sugerencia.']
How deadly is alzheimer?
Alzheimer's disease is a progressive neurological disorder that causes brain cells to degenerate and die, leading to a decline in memory, thinking, and reasoning skills.
It is the most common cause of dementia, accounting for 60-80% of all cases.
The disease is ultimately fatal, with the average life expectancy after diagnosis being 4-8 years, although some people can live up to 20 years with the disease.
The mortality rate for Alzheimer's disease varies depending on the study and the population being examined.
According to the Alzheimer's Association, Alzheimer's disease is the sixth leading cause of death in the United States, and it is the fifth leading cause of death for those aged 65 and older.
In 2019, Alzheimer's disease was reported as the underlying cause of death for 121,9444 people in the United States.
It is important to note that the mortality rate for Alzheimer's disease is not solely due to the disease itself, but also due to complications and other health issues that arise as a result of the disease.
As the disease progresses, individuals may experience difficulty with activities of daily living, such as eating, bathing, and dressing, which can lead to malnutrition, infections, and other health problems.
Additionally, individuals with Alzheimer's disease may be at an increased risk of falls, pneumonia, and other infections.
While there is currently no cure for Alzheimer's disease, there are treatments available that can help manage symptoms and improve quality of life.
Research is ongoing to develop new treatments and ultimately find a cure for this devastating disease.
Disclaimer: medical
This web site is provided for educational and informational purposes only and does not constitute providing medical advice or professional services.
The information provided should not be used for diagnosing or treating a health problem or disease, and those seeking personal medical advice should consult with a licensed physician.
Please note the neural net that generates answers to the questions, is specially inaccurate when it comes to numeric content. For example, the number of people diagnosed with a specific disease.
Always seek the advice of your doctor or other qualified health provider regarding a medical condition. Never disregard professional medical advice or delay in seeking it because of something you have read on this website. If you think you may have a medical emergency, call 911 or go to the nearest emergency room immediately. No physician-patient relationship is created by this web site or its use. Neither BioMedLib nor its employees, nor any contributor to this web site, makes any representations, express or implied, with respect to the information provided herein or to its use.
Disclaimer: copyright
The Digital Millennium Copyright Act of 1998, 17 U.S.C. § 512 (the “DMCA”) provides recourse for copyright owners who believe that material appearing on the Internet infringes their rights under U.S. copyright law. If you believe in good faith that any content or material made available in connection with our website or services infringes your copyright, you (or your agent) may send us a notice requesting that the content or material be removed, or access to it blocked. Notices must be sent in writing by email (see 'Contact' section for email address) . The DMCA requires that your notice of alleged copyright infringement include the following information: (1) description of the copyrighted work that is the subject of claimed infringement; (2) description of the alleged infringing content and information sufficient to permit us to locate the content; (3) contact information for you, including your address, telephone number and email address; (4) a statement by you that you have a good faith belief that the content in the manner complained of is not authorized by the copyright owner, or its agent, or by the operation of any law; (5) a statement by you, signed under penalty of perjury, that the information in the notification is accurate and that you have the authority to enforce the copyrights that are claimed to be infringed; and (6) a physical or electronic signature of the copyright owner or a person authorized to act on the copyright owner’s behalf. Failure to include all of the above information may result in the delay of the processing of your complaint.
['Tokante']
['BioMedLib ta usa kòmpiuter outomátiko (algoritmo di siñamentu di mashin) pa generá par di pregunta i kontesta.']
['Nos ta kuminsá ku 35 mion publikashon biomédico di PubMed/Medline. Tambe página di RefinedWeb.']
